Top compounds associated with response to RP11-146B14.1


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.077 0.04
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.07 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.05
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.069 0.05
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.1 0.05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.05
mRNA tigecycline CTRPv2 pan-cancer AAC 0.11 0.05
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.082 0.05
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.079 0.05
Download CSV